Global Hemostasis and Tissue Sealing Agents Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hemostasis and Tissue Sealing Agents Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing.
Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better Visualization of the surgical area, shorter operative times, decreased requirement for transfusions, decreased wound healing time and overall improvement in patient recovery time.
Hemostasis and Tissue Sealing Agents report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hemostasis and Tissue Sealing Agents market is projected to reach US$ 4961.4 million in 2034, increasing from US$ 3559.5 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2034. Demand from Minimally Invasive Surgery and General Surgery are the major drivers for the industry.
The classification of Hemostasis and Tissue Sealing Agents includes Hemostasis and Tissue Sealing Agents and the revenue proportion of Hemostasis Agent is about 64%.
Hemostasis and Tissue Sealing Agents is widely used for Minimally Invasive Surgery, General Surgery and other field. The most proportion of Hemostasis and Tissue Sealing Agents is used for general surgery, and the proprotion is 44%.
North America is the largest consumption place, with a consumption market share nearly 42%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
Market competition is not intense. Johnson & Johnson, Baxter, C R Bard, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution and Pfizer, etc. are the leaders of the industry, with about 70% market shares.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hemostasis and Tissue Sealing Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Johnson & Johnson
Baxter
C R Bard
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith & Nephew
Z-Medica
Cohera Medical
Marine Polymer
Equimedical
Segment by Type
Hemostasis Agents
Tissue Sealing Agents
Minimally Invasive Surgery
General Surgery
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hemostasis and Tissue Sealing Agents market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hemostasis and Tissue Sealing Agents, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hemostasis and Tissue Sealing Agents industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hemostasis and Tissue Sealing Agents in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hemostasis and Tissue Sealing Agents introduction, etc. Hemostasis and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hemostasis and Tissue Sealing Agents market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better Visualization of the surgical area, shorter operative times, decreased requirement for transfusions, decreased wound healing time and overall improvement in patient recovery time.
Hemostasis and Tissue Sealing Agents report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hemostasis and Tissue Sealing Agents market is projected to reach US$ 4961.4 million in 2034, increasing from US$ 3559.5 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2034. Demand from Minimally Invasive Surgery and General Surgery are the major drivers for the industry.
The classification of Hemostasis and Tissue Sealing Agents includes Hemostasis and Tissue Sealing Agents and the revenue proportion of Hemostasis Agent is about 64%.
Hemostasis and Tissue Sealing Agents is widely used for Minimally Invasive Surgery, General Surgery and other field. The most proportion of Hemostasis and Tissue Sealing Agents is used for general surgery, and the proprotion is 44%.
North America is the largest consumption place, with a consumption market share nearly 42%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
Market competition is not intense. Johnson & Johnson, Baxter, C R Bard, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution and Pfizer, etc. are the leaders of the industry, with about 70% market shares.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hemostasis and Tissue Sealing Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Johnson & Johnson
Baxter
C R Bard
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith & Nephew
Z-Medica
Cohera Medical
Marine Polymer
Equimedical
Segment by Type
Hemostasis Agents
Tissue Sealing Agents
Segment by Application
Minimally Invasive Surgery
General Surgery
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hemostasis and Tissue Sealing Agents market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hemostasis and Tissue Sealing Agents, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hemostasis and Tissue Sealing Agents industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hemostasis and Tissue Sealing Agents in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hemostasis and Tissue Sealing Agents introduction, etc. Hemostasis and Tissue Sealing Agents Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Hemostasis and Tissue Sealing Agents market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices